KELLS Gains Singapore HSA Registration for AI Dental Scan
Singapore and New York, September 16, 2026 KELLS, Inc. has announced that its KELLS AI Dental Scan has been...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Singapore and New York, September 16, 2026 KELLS, Inc. has announced that its KELLS AI Dental Scan has been...
FORT LAUDERDALE, Fla. & TEL AVIV, Israel, July 23, 2026 Momentis Surgical has received U.S. Food and Drug Administration...
PITTSBURGH, USA & BIRMINGHAM, UK, July 23, 2026 MolecuLight and The Royal Orthopaedic Hospital NHS Foundation Trust (ROH) have...
SUNNYVALE, Calif., July 23, 2026 VELMENI AI has received U.S. Food and Drug Administration (FDA) 510(k) clearance for VELMENI...
Westlake, Texas, USA – May 21, 2026 Virbac, a global leader in animal health and veterinary care, announced that...
McLean, Virginia, USA – May 20, 2026 Oryx Dental, a rapidly growing provider of cloud-based and AI-powered dental practice...
JERUSALEM – May 8, 2026 Alpha Tau Medical Ltd. announced the completion of patient enrollment in its pivotal U.S....
SEOUL, South Korea and ALISO VIEJO, Calif. – May 7, 2026 Medit Corp., a global leader in digital dentistry...
